CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-01 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-05-30 | COUGHLIN TIMOTHY Director | Purchase | +50,000 | $1.75 | $88K | 56,000 |
| 2024-05-22 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2023-05-17 | COUGHLIN TIMOTHY Director | Gift | −6,000 | 0 | ||
| 2023-05-17 | COUGHLIN TIMOTHY Director | Gift | +6,000 | 6,000 | ||
| 2023-05-17 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2023-04-26 | COUGHLIN TIMOTHY Director | Exercise or conversion | +6,000 | 6,000 | ||
| 2023-04-26 | COUGHLIN TIMOTHY Director | Exercise or conversion · Restricted Stock Unit | −6,000 | 0 | ||
| 2022-04-26 | COUGHLIN TIMOTHY Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2021-04-28 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2020-05-06 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 |
Page 1 of 1 · 11 trades